nedaplatin has been researched along with Esophageal Neoplasms in 127 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (4.72) | 18.2507 |
| 2000's | 51 (40.16) | 29.6817 |
| 2010's | 63 (49.61) | 24.3611 |
| 2020's | 7 (5.51) | 2.80 |
| Authors | Studies |
|---|---|
| Beeraka, NM; Cai, J; Chen, K; Cui, Y; Fan, R; Fang, X; Greeshma, MV; Jia, Z; Liu, J; Liu, Y; Luo, J; Nikolenko, VN; Qi, X; Ren, J; Sinelnikov, MY; Song, B; Song, X; Song, Z; Wang, H; Wang, X; Wang, Y; Wu, L; Zheng, A | 1 |
| Deng, HZ; Ke, LX; Li, EM; Long, L; Tian, HT; Wu, XY; Xu, LY; Zhang, LT | 1 |
| Ashino, K; Kamio, Y; Kanno, H; Kono, M; Motoi, F; Musha, H; Nakano, R; Nozu, S; Suzuki, T; Takahashi, K | 1 |
| Chen, J; Jiang, T; Wang, W; Xia, Y; Zhang, Y; Zhao, J; Zhu, J | 1 |
| Che, Y; Jiang, C; Li, A; Li, J; Qiu, X; Shen, Z; Wang, Z; Wu, T; Zhang, M; Zhou, H; Zhu, X | 1 |
| Chen, H; Hong, J; Li, C; Lu, Q; Shi, B | 1 |
| Hirakawa, T; Hirata, K; Iwauchi, T; Kurihara, S; Matsutani, S; Miyamoto, H; Morimoto, J; Nagashima, D; Okada, T; Takeuchi, K; Tanaka, H; Tsujio, G; Uchima, Y; Yamagata, S | 1 |
| Abe, O; Nakagawa, K; Yamashita, H | 1 |
| Akimoto, T; Daiko, H; Kojima, T; Kumabe, A; Motegi, A; Nakamura, N; Onozawa, M; Shigematsu, N; Zenda, S | 1 |
| Baatar, S; Gombodorj, N; Kumakura, Y; Kuriyama, K; Kuwano, H; Miyazaki, T; Nishiyama, M; Sakai, M; Shirabe, K; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T; Yoshida, T | 1 |
| Chen, L; Fu, MY; Tian, D; Wang, Y; Wen, HY; Zhang, KP; Zhang, L; Zhou, Y | 1 |
| Dong, Y; Grimm, R; Guo, J; Jiang, L; Kamel, IR; Li, H; Lu, Y; Qin, J; Qu, J; Wang, Z; Yan, X; Zhang, F; Zhang, H; Zhang, S; Zhang, T; Zhang, Z; Zhao, Y | 1 |
| Chikugo, T; Hiraki, Y; Imamoto, H; Imano, M; Iwama, M; Kato, H; Kawakami, H; Kimura, Y; Nakagawa, K; Okuno, T; Shinkai, M; Shiraishi, O; Ueda, H; Yasuda, A; Yasuda, T | 1 |
| Kobayashi, R; Nakagawa, K; Ohtomo, K; Okuma, K; Shiraishi, K; Yamashita, H | 1 |
| Karimata, H; Kinjo, T; Nagahama, M; Nishimaki, T; Shimoji, H | 1 |
| Hasegawa, H; Kondo, S; Kubo, H; Miyahara, M; Nakasuga, C; Tada, K; Yamashita, Y | 1 |
| Chen, J; Fan, PS; He, YF; Hu, B; Hu, CL; Ji, CS; Jiang, FS; Wang, W; Yao, YW; Zhu, L | 1 |
| Igaki, H; Kobayashi, R; Nakagawa, K; Okuma, K; Omori, M; Yamashita, H | 1 |
| Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A; Ueda, Y; Yoshita, H | 1 |
| Egawa, T; Ito, Y; Kemmochi, T; Makino, H; Mihara, K; Mori, T; Nagashima, A; Nishiya, S; Okubo, Y; Sato, S | 1 |
| Amano, R; Hirakawa, K; Kimura, K; Kubo, N; Lee, T; Maeda, K; Muguruma, K; Nagahara, H; Nishimura, J; Ohira, M; Ohtani, H; Sakurai, K; Shibutani, M; Shinto, O; Tanaka, H; Toyokawa, T; Yamazoe, S; Yashiro, M | 1 |
| Li, B; Li, J; Shen, JS; Shen, ZT; Wang, Z; Wu, XH; Zhu, XX | 1 |
| Kigawa, G; Matsubara, T; Matsumiya, A; Mizukami, H; Nemoto, H; Saito, M; Tanaka, J; Tate, G; Umemoto, T | 1 |
| Du, J; Hu, B; Hu, C; Wang, F; Zhang, Y | 1 |
| Kobayashi, R; Nakagawa, K; Ohtomo, K; Okuma, K; Omori, M; Takenaka, R; Yamashita, H | 1 |
| Hu, YH; Li, QQ; Liu, MZ; Wang, QX; Wang, XH; Xiao, WW; Yang, H; Zhang, WW; Zhu, YJ | 1 |
| Fukuchi, M; Ieta, K; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Saito, K; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Nakagawa, K; Takenaka, HY; Yamashita, M | 1 |
| Fujita, H; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Miura, S; Morioka, E; Nakano, Y; Noguchi, M; Ohnishi, T; Ohno, Y; Tomita, Y; Ueda, N | 1 |
| Chen, KN; Chen, Y; Fan, MY; Li, XT; Liang, Z; Sun, Y; Sun, YS; Wang, ZL; Wu, Y; Xiong, HC; Yan, WP; Zhang, XY | 1 |
| Kawakami, H; Nakagawa, K; Nishina, S; Nonagase, Y; Okabe, T; Sakiyama, T; Tamura, T; Ueda, S | 1 |
| Han, S; Liang, H; Liu, W; Wen, H; Yang, H; Yao, J; Yu, L | 1 |
| Hayashi, T; Hirakawa, M; Hori, M; Kato, J; Kobune, M; Miyanishi, K; Nakata, K; Ohnuma, H; Okagawa, Y; Osuga, T; Sagawa, T; Sakata, K; Sato, T; Sato, Y; Someya, M; Takayama, T; Takimoto, R | 1 |
| Imae, T; Nakagawa, K; Ohtomo, K; Okuma, K; Omori, M; Takenaka, R; Yamashita, H | 1 |
| Arimitsu, H; Chibana, T; Hironaka, S; Ikeda, A; Ishige, F; Kainuma, O; Kobayashi, R; Nabeya, Y; Nagata, M; Saito, H; Soda, H; Takiguchi, N; Tonooka, T; Yamamoto, H; Yanagibashi, H | 1 |
| Haga, A; Kiritoshi, T; Nakagawa, K; Ohtomo, K; Okuma, K; Takenaka, R; Yamashita, H | 1 |
| Hara, K; Honjo, H; Kuwano, H; Miyazaki, T; Ozawa, D; Sakai, M; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Aiba, K; Baba, H; Baba, Y; Kitagawa, Y; Miyazaki, T; Nakajima, Y; Shibata, T; Shimada, H; Shimokawa, M; Tsuji, Y; Yamamoto, S; Yoshikawa, T | 1 |
| Matsuhashi, N; Okumura, N; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K | 1 |
| Abe, T; Hazama, S; Kanekiyo, S; Kitahara, M; Michihisa, I; Nagano, H; Nakajima, M; Nishiyama, M; Shindou, Y; Takeda, S; Yoshino, S | 1 |
| Chen, KN; Chen, Y; Li, XT; Sun, YS; Wang, ZL | 1 |
| Jiang, YX; Li, YH; Sun, P; Wang, DS; Wang, FH; Wang, Y; Wang, ZQ; Xu, RH; Zhang, DS; Zhang, F | 1 |
| Fujita, Y; Hiramatsu, M; Kawai, M; Nishimura, H; Sumiyoshi, K; Tanigawa, N | 1 |
| Gong, Y; Hou, M; Huang, M; Lu, Y; Ren, L; Wang, J; Wei, Y; Zhou, L; Zhou, X; Zhu, J | 1 |
| Nishimura, T; Oka, M; Takeda, S; Tokunou, K; Yoshino, S | 2 |
| Chen, XB; Fan, QX; Geng, L; Han, JW; Jiao, ZM; Lu, P; Lu, SP; Lu, TY; Luo, SX; Ma, ZY; Song, M; Wang, GJ; Wang, JS; Wang, R; Wang, RL; Wu, XA; Zhang, MZ; Zhao, YF | 1 |
| Furuta, T; Futami, H; Hamaya, Y; Ikuma, M; Iwaizumi, M; Kodaira, C; Muramatsu, A; Nishino, M; Osawa, S; Sugimoto, K; Takagaki, K; Yamada, T; Yoshida, K | 1 |
| Ariga, T; Kakinohana, Y; Karimata, H; Kasuya, G; Murayama, S; Nishimaki, T; Ogawa, K; Shimoji, H; Tamaki, W; Toita, T | 1 |
| Arai, H; Kobayashi, Y; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Nishi, Y; Sasajima, K; Sugiura, A; Suzuki, S; Tajiri, T; Wakabayashi, H; Yanagi, K; Yokoyama, T | 1 |
| Cao, W; Geng, M; Jiang, J; Jin, Y; Li, H; Lou, G; Xi, W; Xu, C; Zhao, S | 1 |
| Cao, Z; Jin, J; Li, X; Liu, J; Lu, W; Tucker, SJ; Wang, D; Wang, F; Xu, X; Yan, G; Zhong, B | 1 |
| Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Sasajima, K; Suzuki, S; Tajiri, T; Yanagi, K; Yokoyama, T | 1 |
| Fujitani, K; Hirao, M; Makino, T; Mano, M; Takeda, M; Tsujinaka, T | 1 |
| Kobayashi, S; Mori, K; Nakagawa, K; Ohtomo, K; Okuma, K; Seto, Y; Wakui, R; Yamashita, H | 1 |
| Chayahara, N; Inokuma, T; Kataoka, K; Kuwahara, A; Miki, I; Nakamura, T; Nishiguchi, K; Okuno, T; Sakaeda, T; Takemoto, Y; Tamura, T; Yamamori, M | 1 |
| Furuta, T; Hamaya, Y; Ikuma, M; Iwaizumi, M; Kanaoka, S; Kodaira, C; Kosugi, T; Nishino, M; Osawa, S; Sugimoto, K; Takagaki, K; Takayanagi, Y; Terai, T; Yamada, T; Yamade, M; Yoshida, K | 1 |
| Amano, R; Hirakawa, K; Inoue, T; Kubo, N; Maeda, K; Morimoto, J; Muguruma, K; Noda, E; Ohira, M; Sawada, T; Tanaka, H; Yamada, N; Yamashita, Y; Yashiro, M | 1 |
| Doi, T; Hoshi, M; Iijima, S; Kato, A; Kato, T; Kikkawa, N; Kurokawa, E; Makari, Y; Miyake, Y; Miyo, M; Ooshima, S; Sakamoto, T | 1 |
| Dan, N; Hirakawa, K; Kubo, N; Morimoto, J; Muguruma, K; Nishiguchi, Y; Oohira, M; Sawada, T; Tanaka, H; Yamashita, Y; Yashiro, M | 1 |
| Aoyama, N; Minamide, J; Ota, Y; Takata, K | 1 |
| Hirakawa, K; Ishikawa, T; Kubo, N; Maeda, K; Muguruma, K; Noda, S; Ohira, M; Sawada, T; Tanaka, H; Yamada, N; Yashiro, M | 1 |
| Guo, JF; Nie, XY; Peng, J; Wang, B; Wu, F; Xing, H; Zhang, B; Zhu, GY | 1 |
| Hosojima, Y; Miura, T; Nakamura, J; Nakazawa, Y; Ozeki, Y; Takahashi, T; Yamada, S; Yamazaki, H; Yanagi, M | 1 |
| Ise, M; Kumagai, K; Mimura, N; Nagata, M; Sakai, C; Takagi, T; Tsujimura, H | 1 |
| Hayashi, S; Karaki, H; Okaya, T; Sasaki, K; Sugano, I; Sugimoto, K; Suzuki, H; Yamamori, H; Yamamoto, K | 1 |
| Egawa, S; Furuya, A; Kobayashi, S; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H | 1 |
| Gyobu, K; Hashiba, R; Isohata, N; Iwasaki, H; Kishida, S; Lee, S; Matsuda, Y; Mori, K; Osugi, H | 1 |
| Arai, H; Hirakata, A; Kawamoto, M; Maruyama, H; Matsushita, A; Matsutani, T; Sasajima, K; Suzuki, S; Uchida, E; Umakoshi, M; Wakabayashi, H; Yokoyama, T | 1 |
| Akutsu, Y; Kono, T; Matsubara, H; Natsume, T; Ohira, G; Ota, T; Saito, H; Shuto, K; Toma, T; Uesato, M | 1 |
| Hatooka, S; Kodaira, T; Kondoh, C; Mizota, A; Muro, K; Nomura, M; Shitara, K; Takahari, D; Ura, T; Yokota, T | 1 |
| Arai, H; Hirakata, A; Kawamoto, M; Maruyama, H; Matsushita, A; Matsutani, T; Sasajima, K; Suzuki, S; Uchida, E; Umakoshi, M; Wakabayashi, H; Yokoyama, T; Yoshida, H | 1 |
| Fukui, T; Itoh, Y; Kawada, S; Takeda, H; Yoshioka, T | 1 |
| Itasaka, S; Itoh, Y; Koike, R; Murakami, Y; Negoro, Y; Nishimura, Y; Ogawa, K; Sakayauchi, T; Sasamoto, R; Tamamoto, T | 1 |
| Ariga, H; Jingu, K; Koto, M; Kubozono, M; Miyata, G; Narazaki, K; Nemoto, K; Onodera, K; Sugawara, T; Takeda, K; Umezawa, R; Yamada, S | 1 |
| Fukui, T; Itoh, Y; Kawada, S; Orihara, M; Takeda, H; Yoshioka, T; Yoshizawa, K | 1 |
| Fujitani, K; Hasegawa, H; Hirao, M; Mita, E; Nakazuru, S; Tsujinaka, T | 1 |
| Osada, S; Takahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K | 1 |
| Hakamada, K; Kawasaki, H; Kubo, N; Maruyama, M; Miyamoto, K; Takahashi, K; Wajima, N | 1 |
| Egawa, T; Eto, E; Inaba, Y; Irino, T; Ito, Y; Kenmochi, T; Mihara, K; Murakawa, M; Nagashima, A; Okamura, A | 1 |
| Akanuma, N; Akutsu, Y; Hoshino, I; Isozaki, Y; Kono, T; Matsubara, H; Miyazawa, Y; Shiratori, T; Shuto, K; Uesato, M | 1 |
| Cai, L; Guo, K; Hao, CL; Li, Z; Lin, P; Rong, TH; Wang, WP; Zhang, LJ; Zhang, Y; Zhu, JF | 1 |
| Haruma, K; Higashida, M; Hirabayashi, Y; Hirai, T; Hiratsuka, J; Kubota, H; Matsumoto, H; Murakami, H; Nakamura, M | 1 |
| Ariga, H; Jingu, K; Matsushita, H; Miyata, G; Narazaki, K; Nemoto, K; Onodera, K; Sugawara, T; Takeda, K; Umezawa, R; Yamada, S | 1 |
| Gu, J; Li, YM; Wang, HX; Wang, M; Wang, YJ; Wu, MH | 1 |
| Bi, LW; Zhang, LZ; Zhao, HF | 1 |
| Dai, HY; Huang, XE; Li, SY; Shi, FF; Su, XY; Tan, HY; Yin, HT | 1 |
| Abe, K; Ishikawa, Y; Jingu, K; Kubozono, M; Matsushita, H; Nemoto, K; Shirata, Y; Sugawara, T; Takahashi, C; Takeda, K; Tanabe, T; Umezawa, R; Yamamoto, T | 1 |
| Deguchi, K; Deguchi, T; Fukui, A; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Nomura, M; Omori, K; Takagi, M; Tamagawa, H; Tanaka, Y | 1 |
| Fukuchi, M; Ieta, K; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T | 1 |
| Kimura, M; Masuda, K; Nakamura, K; Ohga, S; Sasaki, T; Terashima, H; Toba, T; Urashima, Y | 1 |
| Endo, T; Hara, T; Hoshikawa, Y; Iino, S; Inaba, H; Kato, N; Kitajima, S; Kobayashi, Y; Koitabashi, Y; Miyazaki, A; Nakagawa, T; Nakaya, S; Ogihara, K; Tsuda, T; Watanabe, Y | 1 |
| Kawasaki, H; Matsuya, H; Morita, T; Morohashi, H; Nakai, M; Sasaki, M; Shibata, S; Yamada, K | 1 |
| Britton, KR; Matsushita, H; Miyata, T; Miyazaki, S; Nemoto, K; Ogawa, Y; Takahashi, C; Takai, Y; Takeda, K; Yamada, S | 1 |
| Iwashige, M; Kikuchi, H; Kumada, K; Midorikawa, T; Nagasaki, H; Nemoto, H; Sanada, Y; Takeuchi, S; Takizawa, K; Tate, G; Yagi, H; Yoshizawa, Y | 1 |
| Futami, R; Makino, H; Maruyama, H; Miyashita, M; Miyashita, T; Nomura, T; Sasajima, K; Tajiri, T; Tateno, A | 1 |
| Eguchi, R; Hayashi, K; Ide, H; Mitsuhashi, M; Nakamura, T; Narumiya, K; Ota, M; Takasaki, K | 1 |
| Fujitani, K; Hirao, M; Tsujinaka, T | 2 |
| Fujiwara, Y; Higashino, M; Iwasaki, H; Kaneko, M; Lee, S; Nishizawa, S; Osugi, H; Takemura, M; Tanaka, Y | 1 |
| Abiko, R; Akasaka, H; Fujita, K; Hoshikawa, Y; Inaba, H; Itoh, F; Katoh, N; Kimura, M; Kitajima, S; Kobayashi, M; Koro, T; Miyazaki, A; Nakaya, S; Ogihara, K; Okamoto, M; Tsuda, T; Watanabe, Y; Yamauchi, S | 1 |
| Matsumoto, T; Mikami, T; Momokawa, K; Nakamura, Y; Sakayauchi, T; Sasaki, T; Watanabe, T | 1 |
| Fukuhara, K; Iwasaki, H; Lee, S; Nishikawa, T; Osugi, H; Takemura, M | 1 |
| Maruyama, K; Motoyama, S; Ogawa, J; Ohta, H; Okuyama, M; Oyake, J; Tsuchiya, N | 1 |
| Hatakeyama, K; Kanda, T; Kosugi, S; Nakagawa, S; Nishimaki, T; Ohashi, M | 1 |
| Igaki, H; Nakagawa, K; Nakamura, N; Ohtomo, K; Sasano, N; Shiraishi, K; Tago, M; Yamashita, H | 1 |
| Abe, S; Araki, H; Hareyama, M; Iyama, S; Kato, J; Miyanishi, K; Murase, K; Nagakura, H; Niitsu, Y; Okamoto, T; Sagawa, T; Sato, T; Sato, Y; Takayama, T; Takimoto, R | 1 |
| Jingu, K; Matsushita, H; Nakata, E; Nemoto, K; Ogawa, Y; Sugawara, T; Takahashi, C; Takai, Y; Yamada, S | 1 |
| Feng, FY; Gao, YJ; Guan, XQ; Hu, Y; Li, CW; Liu, JW; Nan, KJ; Suo, AL; Wang, XW; Wu, LY; Zhang, MH; Zhang, P; Zhang, WD; Zhang, Y; Zhao, JB | 1 |
| Aoki, T; Hoshino, S; Osaka, Y; Tachibana, S; Takagi, Y; Tsuchida, A | 1 |
| Dai, AD; Guan, ZZ; Hu, XH; Huang, H; Jiang, WQ; Li, XG; Liu, YL; Ma, ZY; Pan, LX; Shi, YX; Wang, JH; Xie, WM; Xu, RH; Zhang, C; Zhuang, W | 1 |
| Chiba, N; Ishioka, C; Kakudo, Y; Kato, S; Miyazaki, S; Nemoto, K; Ohtsuka, K; Sakata, Y; Sakayori, M; Shibata, H; Shimodaira, H; Yoshioka, T | 1 |
| Higashida, M; Hirabayashi, Y; Hirai, T; Kawabe, Y; Matsumoto, H; Murakami, H; Tsunoda, T; Urakami, A; Yamashita, K | 1 |
| Chiba, T; Fukushima, M; Ishiguro, H; Kanai, M; Kitano, T; Matsumoto, S; Misawa, A; Mitsumori, M; Nishimura, T; Sakai, Y; Shimada, Y; Teramukai, S; Watanabe, G; Yanagihara, K; Yoshikawa, K | 1 |
| Imawari, M; Inoue, T; Kaneko, K; Kiuchi, Y; Kogo, M; Tomura, K; Yoneyama, K | 1 |
| Imawari, M; Kaneko, K; Kiuchi, Y; Kogo, M; Suzuki, A; Yoneyama, K | 1 |
| Boku, N; Fukutomi, A; Hasuike, N; Hironaka, S; Inui, T; Ono, H; Onozawa, Y; Yamaguchi, Y; Yamazaki, K; Yasui, H; Yoshino, T | 1 |
| Kato, Y; Kono, K; Kuroda, Y; Kusumi, F; Murakami, M; Okamoto, Y; Takakita, S; Takeda, H; Yoden, E | 1 |
| Asai, A; Hioki, K; Michiura, T; Mori, T; Motohiro, T; Yamanaka, H | 1 |
| Fukuda, S; Hizawa, Y; Munakata, A; Saitoh, S; Sakata, Y; Satoh, T; Takasugi, T; Tamura, Y; Tohno, H; Tsushima, K; Yamada, Y | 1 |
| Gamoh, M; Ishibashi, S; Ishioka, C; Kanamaru, R; Kato, S; Murakawa, Y; Shibata, H; Shimodaira, H; Shineha, R; Suzuki, T; Yoshioka, T | 1 |
| Atsuta, Y; Hirata, S; Kokubo, T; Kosiko, S; Miyokawa, N; Sasajima, T; Sugimoto, Y; Yamazaki, H; Yatsuyanagi, E | 1 |
| Boku, N; Hosokawa, K; Ishikura, S; Muto, M; Nagashima, F; Ogino, T; Ohtsu, A; Satake, M; Sumi, H; Yoshida, S | 1 |
| Asano, T; Gunji, Y; Koide, Y; Maeda, T; Matsubara, H; Ochiai, T; Sakiyama, S; Tagawa, M | 1 |
| Eguchi, J; Ito, H; Ito, T; Kaneko, K; Kitahara, T; Konishi, K; Kurahashi, T; Mitamura, K; Yamamoto, T | 1 |
| Isono, K; Kakegawa, T; Kurihara, M; Nabeya, K; Ota, K; Taguchi, T; Wakui, A | 1 |
| Ikeda, K; Ishida, K; Kawamura, S; Maesawa, C; Okamoto, K; Saito, K; Satoh, M; Sudoh, T; Takagane, A; Terashima, M | 1 |
3 review(s) available for nedaplatin and Esophageal Neoplasms
| Article | Year |
|---|---|
[Hyperammonemia with Disturbance of Consciousness during 5-FU plus Nedaplatin Therapy for Esophageal Cancer-A Case Report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Consciousness; Esophageal Neoplasms; Fluorouracil; Humans; Hyperammonemia; Japan; Male; Organoplatinum Compounds | 2020 |
Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Treatment Outcome | 2017 |
[A case of long-term survival after resection for postoperative solitary adrenal metastasis from esophageal adenocarcinoma].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Male; Organoplatinum Compounds; Positron-Emission Tomography | 2010 |
29 trial(s) available for nedaplatin and Esophageal Neoplasms
| Article | Year |
|---|---|
Comparative clinical studies of primary chemoradiotherapy versus S-1 and nedaplatin chemotherapy against stage IVb oesophageal squamous cell carcinoma: a multicentre open-label randomised controlled trial.
Topics: Chemoradiotherapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Organoplatinum Compounds | 2022 |
Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Longitudinal Studies; Male; Middle Aged; Organoplatinum Compounds; Quinazolines; Retrospective Studies; Thiophenes; Treatment Outcome | 2020 |
Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Irinotecan; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Prospective Studies; Survival Rate; Treatment Outcome | 2019 |
A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; China; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Paclitaxel; Time Factors; Treatment Outcome | 2013 |
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Taxoids; Treatment Failure; Vomiting | 2016 |
Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; China; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy Dosage; Radiotherapy, Conformal; Survival Rate; Time Factors; Treatment Outcome; Young Adult | 2013 |
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Positron-Emission Tomography; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Survival Rate | 2014 |
Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Prospective Studies; Survival Rate; Taxoids; Treatment Outcome | 2015 |
Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Young Adult | 2015 |
[Clinical evaluations of neoadjuvant chemotherapy with DN and FP regimens for patients with middle or lower thoracic locally advanced esophageal squamous cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Survival Rate; Taxoids | 2015 |
A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagitis; Feasibility Studies; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Pneumonia; Radiotherapy Dosage; Stomatitis; Taxoids | 2015 |
Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxonic Acid; Taxoids; Tegafur; Treatment Outcome | 2016 |
Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Treatment Outcome | 2016 |
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2009 |
A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Esophageal Neoplasms; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2009 |
Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Radiotherapy; Treatment Outcome | 2009 |
A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia | 2010 |
Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Taxoids; Tegafur; Tomography, X-Ray Computed | 2011 |
A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Taxoids; Time Factors; Treatment Outcome | 2012 |
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Postoperative Period; Prognosis; Stomach Neoplasms; Time Factors; Treatment Outcome | 2012 |
Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Prognosis; Prospective Studies; Taxoids | 2013 |
Phase I study of the combination of nedaplatin, adriamycin and 5-fluorouracil for treatment of advanced esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Platelet Count; Treatment Outcome | 2004 |
[Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds | 2005 |
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Radiotherapy, Adjuvant; Remission Induction; Severity of Illness Index; Survival Rate; Thrombocytopenia; Treatment Outcome | 2006 |
Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Radiotherapy Dosage; Survival Rate | 2006 |
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Vinblastine; Vinorelbine | 2006 |
[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nausea; Neutropenia; Organoplatinum Compounds; Prospective Studies; Remission Induction; Thrombocytopenia | 2006 |
A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Pilot Projects; Prognosis | 1999 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Esophageal Neoplasms; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Nausea; Organoplatinum Compounds; Stomach Neoplasms; Thrombocytopenia | 1992 |
95 other study(ies) available for nedaplatin and Esophageal Neoplasms
| Article | Year |
|---|---|
TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis.
Topics: Apoptosis; ATPases Associated with Diverse Cellular Activities; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Damage; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Organoplatinum Compounds; Prognosis | 2022 |
[A Case of Long-Term Survival by Multidisciplinary Surgical Treatment for Metastatic Multi-Organ Metastasis after Radical Resection of Esophageal Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lung Neoplasms; Male; Nivolumab | 2022 |
Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study.
Topics: Albumin-Bound Paclitaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Neoadjuvant Therapy; Retrospective Studies | 2023 |
Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azygos Vein; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Thrombosis | 2020 |
Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Organoplatinum Compounds; Positron-Emission Tomography | 2017 |
Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Organoplatinum Compounds; Treatment Outcome | 2017 |
Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Nucleus; Chemoradiotherapy, Adjuvant; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; F-Box-WD Repeat-Containing Protein 7; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Neoadjuvant Therapy; Organoplatinum Compounds; Retrospective Studies; Taxoids | 2018 |
Accuracy of 3-T MRI for Preoperative T Staging of Esophageal Cancer After Neoadjuvant Chemotherapy, With Histopathologic Correlation.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Contrast Media; Esophageal Neoplasms; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prospective Studies | 2019 |
[A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Taxoids | 2018 |
Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinosarcoma; Chemoradiotherapy; Cisplatin; Cohort Studies; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxonic Acid; Pyridines; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Tegafur; Treatment Outcome | 2014 |
Clinical and oncological effects of triplet chemotherapy followed by radical esophagectomy for resectable esophageal cancer associated with unfavorable prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Prognosis; Prospective Studies; Survival Rate | 2014 |
[A case of advanced esophageal cancer revealed a pathological complete response and survived more than 8 years, treated by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Time Factors | 2013 |
Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Longitudinal Studies; Male; Middle Aged; Nausea; Organoplatinum Compounds; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vomiting | 2014 |
[A case of liver metastasis from esophageal cancer treated with stereotactic body radiation therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Docetaxel; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Organoplatinum Compounds; Recurrence; Taxoids; Treatment Outcome; Whole-Body Irradiation | 2013 |
[Successful treatment of locally advanced squamous cell carcinoma of the esophagus by combination chemotherapy with 5-fluorouracil plus nedaplatin following tracheal stent tube placement-a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Humans; Male; Organoplatinum Compounds; Stents; Trachea | 2013 |
[A case of esophageal squamous cell carcinoma with an adenocarcinoma component that dedifferentiated after chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Differentiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Recurrence | 2014 |
A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Organoplatinum Compounds; Paclitaxel; Retrospective Studies | 2015 |
Concurrent radiotherapy and weekly chemotherapy of 5-fluorouracil and platinum agents for postoperative locoregional recurrence of oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Japan; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
[Evaluation of combination chemotherapy with docetaxel and nedaplatin in patients with advanced or recurrent esophageal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence; Taxoids | 2014 |
CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Preoperative Care; Prognosis; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Irradiation; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies | 2015 |
[A Case of Early Recurrence after Esophagectomy for Cancer Following Neoadjuvant Chemotherapy Resulting in a Complete Response of the Primary Lesion].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Recurrence; Time Factors | 2015 |
Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Retrospective Studies; Salvage Therapy; Tegafur | 2016 |
Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography for Predicting the Pathological Response of Neoadjuvant Chemoradiotherapy for T4 Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Taxoids; Treatment Outcome | 2015 |
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Esophageal Neoplasms; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nausea; Organoplatinum Compounds; Prospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2017 |
Potential of Baseline Computed Tomography to Predict Long-Term Survival of Patients With Locally Advanced Esophageal Cancer Treated With Preoperative Chemotherapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Probability; Retrospective Studies; Risk Assessment; Survival Analysis; Taxoids; Treatment Outcome | 2008 |
[A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Taxoids; Tomography, X-Ray Computed; Tumor Lysis Syndrome | 2008 |
[A case of esophageal cancer with recurrent lymph-node metastasis successfully treated with chemo-radiotherapy after mediastinoscopy-assisted transhiatal esophagectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Organoplatinum Compounds; Recurrence; Remission Induction; Tomography, X-Ray Computed | 2008 |
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Tegafur; Vomiting | 2008 |
[A case of elderly esophageal adenocarcinoma successfully treated with daily low-dose nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Male; Organoplatinum Compounds; Radiography | 2009 |
Development of gastro-lymphatic fistula during chemoradiotherapy for advanced esophageal cancer: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Fatal Outcome; Fluorouracil; Gastric Fistula; Humans; Lymphatic Diseases; Male; Middle Aged; Organoplatinum Compounds | 2009 |
[A case of double advanced cancer with esophageal and hypopharyngeal carcinoma responding completely to combination chemotherapy of docetaxel/5-fluorouracil and nedaplatin with radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagoscopy; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Remission Induction; Taxoids; Tomography, X-Ray Computed | 2009 |
Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Salvage Therapy; Survival Rate; Taxoids; Treatment Outcome | 2009 |
[A case of the oldest old patient with advanced esophageal cancer responding completely to the combination chemotherapy of docetaxel/5-fluorouracil/nedaplatin with radiation].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Organoplatinum Compounds; Taxoids | 2009 |
Sustained complete response following combined nedaplatin+ adriamycin+5-fluorouracil therapy in a patient with superficial esophageal cancer -case report-.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Treatment Outcome | 2009 |
A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Organoplatinum Compounds; Quality of Life; Radiotherapy, Adjuvant; Retrospective Studies; Sex Factors; Survival Rate | 2009 |
Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Circadian Rhythm; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Japan; Middle Aged; Organoplatinum Compounds; Treatment Outcome | 2009 |
[Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds | 2009 |
[A case of a 14-month survival patient on advanced esophageal cancer with uncontrolled brain metastasis completely responding to nedaplatin, adriamycin, plus 5-FU (NAF) therapy].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds | 2009 |
[A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Gastrectomy; Humans; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Stomach Neoplasms | 2009 |
[A case of advanced esophageal cancer that has come back eight years after combined modality therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Organoplatinum Compounds; Time Factors | 2009 |
[A case of advanced esophageal cancer with para-aortic lymph node metastasis with complete response (CR) to combination chemotherapy including nedaplatin].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds | 2009 |
[An elderly hemodialytic case of recurrent esophageal cancer given combination chemotherapy with docetaxel and nedaplatin who showed temporal relief of swallowing disturbance].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deglutition; Docetaxel; Esophageal Neoplasms; Fatal Outcome; Humans; Male; Myocardial Infarction; Neoplasm Recurrence, Local; Organoplatinum Compounds; Quality of Life; Renal Dialysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Therapy-related leukemia following chemoradiotherapy for esophageal cancer.
Topics: Aged; Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human, Pair 5; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Organoplatinum Compounds; Radiotherapy | 2010 |
[A case of advanced esophageal cancer with no recurrence treated biweekly with postoperative docetaxel/nedaplatin combined chemotherapy after non-curative surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Humans; Neoplasm Staging; Organoplatinum Compounds; Remission Induction; Taxoids | 2010 |
[Effects of concurrent S-1, nedaplatin/radiation therapy for 5 cases of head and neck cancer with esophageal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Fatal Outcome; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxonic Acid; Tegafur | 2010 |
[A case of SIADH developed during neoadjuvant chemotherapy using nedaplatin and 5-fluorouracil in a patient with esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Esophageal Neoplasms; Fluorouracil; Humans; Inappropriate ADH Syndrome; Male; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Tomography, X-Ray Computed | 2010 |
[A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatal Outcome; Fluorouracil; Humans; Male; Neoplasm Staging; Organoplatinum Compounds; Stomach Neoplasms; Taxoids | 2010 |
Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Organoplatinum Compounds; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sex Factors; Survival Rate; Tumor Burden; United States | 2012 |
[A case of advanced esophageal carcinoma with nephrotic syndrome completely responding to chemotherapy of docetaxel, nedaplatin and 5-fluorouracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Neoplasm Staging; Nephrotic Syndrome; Organoplatinum Compounds; Remission Induction; Taxoids; Tomography, X-Ray Computed | 2011 |
[A case of advanced esophageal cancer with multiple liver metastases accompanying poorly general conditions and serious liver dysfunctions, successfully treated using concurrent radiotherapy and chemotherapy with low-dose nedaplatin and 5-fluorouracil].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds | 2011 |
Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Fluorouracil; Humans; Japan; Middle Aged; Organoplatinum Compounds; Radiation Dosage; Surveys and Questionnaires; Survival Analysis | 2012 |
Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Japan; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Survival Analysis; Taxoids | 2012 |
[Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Food, Formulated; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Stomatitis | 2011 |
[Efficacy of combined chemotherapy with nedaplatin, adriamycin, and 5-FU (NAF), and clinical factors affecting its effect in patients with advanced esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds | 2011 |
[A case of advanced esophageal cancer patient surviving more than 7 years treated with chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Fluorouracil; Humans; Male; Neoplasm Staging; Organoplatinum Compounds; Time Factors | 2011 |
[Efficacy and safety of biweekly nedaplatin in combination with docetaxel as second-line chemotherapy in patients with unresectable or recurrent esophageal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Recurrence; Retrospective Studies; Salvage Therapy; Taxoids | 2011 |
The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Organoplatinum Compounds; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Survival Rate; Taxoids | 2012 |
A combined therapy with docetaxel and nedaplatin for relapsed and metastatic esophageal carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids | 2012 |
Results of chemoradiotherapy for stage I esophageal cancer in medically inoperable patients compared with results in operable patients.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Survival Rate | 2013 |
Retrospective study of gemcitabine based chemotherapy for unresectable or recurrent esophagus squamous cell carcinoma refractory to first line chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2012 |
[Efficacy of docetaxel and nedaplatin combined with concurrent intensity modulated radiation therapy in the treatment of esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy, Intensity-Modulated; Remission Induction; Survival Rate; Taxoids; Vomiting | 2012 |
Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Cisplatin; Drug Synergism; Esophageal Neoplasms; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Ki-67 Antigen; Organoplatinum Compounds; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 2012 |
[Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Taxoids | 2012 |
[A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Remission Induction | 2002 |
[Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy Dosage | 2002 |
[Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Radiotherapy Dosage; Treatment Outcome | 2002 |
Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Pilot Projects; Radiotherapy Dosage; Survival Analysis | 2003 |
[Complete remission of esophageal undifferentiated carcinoma with nedaplatin and 5-FU chemotherapy and endoesophageal brachytherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Organoplatinum Compounds; Radiotherapy Dosage; Remission Induction | 2003 |
[Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Endothelial Growth Factors; Esophageal Neoplasms; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Leucovorin; Lymphatic Metastasis; Lymphokines; Male; Middle Aged; Organoplatinum Compounds; Tracheal Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
[Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Organoplatinum Compounds; Pilot Projects; Radiotherapy Dosage | 2003 |
[A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Male; Organoplatinum Compounds; Remission Induction | 2004 |
[Pilot study of concomitant TS-1/CDGP radiotherapy for esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Organoplatinum Compounds; Oxonic Acid; Pilot Projects; Pyridines; Quality of Life; Survival Rate; Tegafur | 2005 |
[Effect of steroid on antiemetic for side effect of anticancer chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Fluorouracil; Humans; Male; Metoclopramide; Middle Aged; Nausea; Organoplatinum Compounds; Serotonin Antagonists; Stomach Neoplasms; Vomiting, Anticipatory | 2005 |
[Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Gastrectomy; Humans; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Remission Induction | 2005 |
[Chemotherapy for an esophageal cancer patient undergoing continuous ambulatory peritoneal dialysis for chronic renal failure and measurement of plasma concentration of the drug].
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organoplatinum Compounds; Peritoneal Dialysis, Continuous Ambulatory | 2005 |
Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2005 |
Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2006 |
Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids | 2006 |
Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Remission Induction; Salvage Therapy; Taxoids | 2006 |
[A feasible study of docetaxel/nedaplatin combined chemotherapy for relapsed or refractory esophageal cancer patients as a 2nd-line chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Feasibility Studies; Humans; Infusions, Intravenous; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids | 2007 |
Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Salvage Therapy; Survival Analysis; Taxoids | 2007 |
[Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cost-Benefit Analysis; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Markov Chains; Middle Aged; Organoplatinum Compounds; Survival Rate | 2007 |
Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Outcome Assessment, Health Care; Predictive Value of Tests; Retrospective Studies | 2008 |
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2008 |
[A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lymph Nodes; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy, High-Energy | 1997 |
Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds | 1998 |
A case of advanced esophageal cancer showing a long-term complete response with chemotherapy with nedaplatin alone.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administration Schedule; Esophageal Neoplasms; Esophagoscopy; Humans; Infusions, Intravenous; Male; Middle Aged; Organoplatinum Compounds; Radiography | 1999 |
[Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone].
Topics: Aged; Antineoplastic Agents; Cell Cycle; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tumor Suppressor Protein p53 | 2000 |
A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemoradiotherapy including nedaplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy Dosage; Survivors | 2000 |
Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Electroporation; Esophageal Neoplasms; Genes, p53; Genetic Therapy; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Organoplatinum Compounds; Transfection; Tumor Suppressor Protein p53 | 2001 |
[A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Male; Organoplatinum Compounds | 2001 |
[Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Esophageal Neoplasms; Humans; Mice; Mice, Nude; Organoplatinum Compounds; Subrenal Capsule Assay | 1990 |